Detalhe da pesquisa
1.
[Combating antimicrobial resistance: audits of practices to target actions]. / Lutte contre l'antibiorésistance : audits des pratiques pour cibler les actions.
Rev Med Suisse
; 20(869): 739-742, 2024 Apr 10.
Artigo
Francês
| MEDLINE | ID: mdl-38616684
2.
Upfront use of eculizumab to treat early acute antibody-mediated rejection after kidney allotransplantation and relevance for xenotransplantation.
Xenotransplantation
; 27(4): e12630, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32698246
3.
[The best time for a medication: how to sweeten the pill ?] / Le bon moment pour un médicament: comment faire passer la pilule ?
Rev Med Suisse
; 16(716): 2254-2258, 2020 Nov 25.
Artigo
Francês
| MEDLINE | ID: mdl-33237642
4.
[Post-transplantation diabetes in kidney transplant: from the diabetologist point of view]. / Diabète post-transplantation rénale: le point de vue du diabétologue.
Rev Med Suisse
; 16(697): 1200-1205, 2020 Jun 10.
Artigo
Francês
| MEDLINE | ID: mdl-32520459
5.
Investigations of an increased incidence of non-Aspergillus invasive mould infections in an onco-haematology unit.
Swiss Med Wkly
; 154: 3730, 2024 Mar 26.
Artigo
Inglês
| MEDLINE | ID: mdl-38579310
6.
Infectious complications and graft outcome following treatment of acute antibody-mediated rejection after kidney transplantation: A nationwide cohort study.
PLoS One
; 16(4): e0250829, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33930037
7.
Ganciclovir exposure under a 450 mg daily dosage of valganciclovir for cytomegalovirus prevention in kidney transplantation: a prospective study.
Clin Transplant
; 24(6): 794-800, 2010.
Artigo
Inglês
| MEDLINE | ID: mdl-20105200
8.
Variable viral clearance despite adequate ganciclovir plasma levels during valganciclovir treatment for cytomegalovirus disease in D+/R- transplant recipients.
BMC Infect Dis
; 10: 2, 2010 Jan 06.
Artigo
Inglês
| MEDLINE | ID: mdl-20053269
9.
Pharmacokinetic parameters of artesunate and dihydroartemisinin in rats infected with Fasciola hepatica.
J Antimicrob Chemother
; 63(3): 543-9, 2009 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-19168863
10.
Biases affecting injected doses of an experimental drug during clinical trials.
Trials
; 17(1): 321, 2016 07 16.
Artigo
Inglês
| MEDLINE | ID: mdl-27423899
11.
A retrospective study of deep sternal wound infections: clinical and microbiological characteristics, treatment, and risk factors for complications.
Diagn Microbiol Infect Dis
; 84(3): 261-5, 2016 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-26707065
12.
Daptomycin-associated eosinophilic pneumonia in two patients with prosthetic joint infection.
Surg Infect (Larchmt)
; 15(6): 834-7, 2014 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-25317960
13.
Stress ulcer prophylaxis in non-critically ill patients: a prospective evaluation of current practice in a general surgery department.
J Eval Clin Pract
; 19(2): 374-8, 2013 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-22420909
14.
Valganciclovir to prevent or treat cytomegalovirus disease in organ transplantation.
Expert Rev Anti Infect Ther
; 9(11): 955-65, 2011 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-22029513
15.
The importance of assessing the dose actually administered in pharmacokinetic trials.
Clin Pharmacol Ther
; 77(4): 235-40, 2005 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-15903121
16.
Efficacy and safety of high-dose daptomycin (>6 mg/kg) for complicated bone and joint infections and implant-associated infections caused by Gram-positive bacteria.
Int J Antimicrob Agents
; 46(4): 480-2, 2015 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-26235888
17.
Valganciclovir in adult solid organ transplant recipients: pharmacokinetic and pharmacodynamic characteristics and clinical interpretation of plasma concentration measurements.
Clin Pharmacokinet
; 48(6): 399-418, 2009.
Artigo
Inglês
| MEDLINE | ID: mdl-19650679
18.
Evolving trends in the costs associated with hospital use of immunosuppressive drugs.
Transplantation
; 95(5): e24-5, 2013 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-23503507